Pfizer
Latest Stories
BELTWAY virus_outbreak__71918.jpg
In this Thursday, Feb. 11, 2021, file photo, pharmacy technician Sochi Evans fills a syringe with a Pfizer-BioNTech COVID-19 vaccine at Texas Southern University in Houston. (Brett Coomer/Houston Chronicle via AP, File)
Virus_Outbreak_Boosters_84787.jpg-4c79a.jpg
Nurse Mary Ezzat prepares to administer a Pfizer COVID-19 booster shot. (Jeff Gritchen/The Orange County Register via AP)
virsus_outbreak_texas_27277.jpg
A vaccination record card is shown during a COVID-19 vaccination drive for Spring Branch Independent School District education workers Tuesday, March 16, 2021, in Houston. School employees who registered were given the Pfizer vaccine.(AP Photo/David J. Phillip)
1_252021_metro-region-laquan8202.jpg
District of Columbia Health Officer Dr. LaQuandra Nesbitt speaks during a news conference following an event to administer the Pfizer-BioNTech vaccine for COVID-19 to front-line workers during a vaccine event at Kaiser Permanente Capitol Hill Medical Center in Washington, Thursday, Dec. 17, 2020. (Shawn Thew/Pool via AP) **FILE**
trump_68298.jpg
President Donald Trump speaks during an event to announce a Merck, Pfizer, and Corning joint partnership to make glass containers for medication, in the Roosevelt Room of the White House, Thursday, July 20, 2017, in Washington. With Trump are Rep. Tom Reed, R-N.Y., left, and Health and Human Services Secretary Tom Price. (AP Photo/Alex Brandon)
Trump_53161.jpg-68532.jpg
President Donald Trump stands during an event to announce a Merck, Pfizer, and Corning joint partnership to make glass containers for medication, in the Roosevelt Room of the White House, Thursday, July 20, 2017, in Washington. (AP Photo/Alex Brandon)
pfizer-j_j-biosimilar.jpeg
In this Monday, Nov. 23, 2015, photo, flags fly in front of Pfizer World Headquarters, in New York. Drugmaker Pfizer said that in November 2016 it will launch a less-expensive version of rival Johnson & Johnson’s blockbuster immune disorder drug, Remicade. Pfizer’s version, called Inflectra, will hit pharmacies in late November. It will be only the second so-called biosimilar drug available in the U.S. (AP Photo/Mark Lennihan)
pfizer_split_decision.jpeg
In this Monday, Nov. 23, 2015, file photo, a man enters Pfizer's world headquarters, in New York. Pfizer will not split into two publicly traded companies, a decision that, at least for now, ends Wall Street speculation over the drugmaker's future. The company believes it is best positioned to maximize shareholder value in its current form, but said Monday, Sept. 26, 2016, that it's reserving the right to split in the future if the situation changes. (AP Photo/Mark Lennihan, File)
Pfizer Allergan.JPEG-0bbfd.jpg
In this Nov. 23, 2015, file photo, traders James Matthews, left, and John Panin work at the post that handles Pfizer, on the floor of the New York Stock Exchange. Allergan and Pfizer called off Wednesday, April 6, 2016, a record $160 billion merger after the Treasury issued new rules to make "tax inversions" less lucrative. (AP Photo/Richard Drew, File)
earns_pfizer.jpeg
FILE - In this Monday, Nov. 23, 2015, file photo, the Pfizer logo is displayed at world headquarters, in New York. Pfizer reports financial results, Tuesday, Feb. 2, 2016. (AP Photo/Mark Lennihan, File)
PFIZER.jpg
A woman passes Pfizer's world headquarters, Monday, Nov. 23, 2015, in New York. Pfizer and Allergan will join in a $160 billion deal to create the world's largest drugmaker. (AP Photo/Mark Lennihan)
2464f59a9d3a3630860f6a7067007a34.jpg
The logo for Pfizer is displayed on a trading post on the floor of the New York Stock Exchange, Thursday, Oct. 29, 2015. (AP Photo/Richard Drew) ** FILE **
abce162792834714550f6a70670050b5.jpg
FILE - This July 24, 2013 file photo shows the AstraZeneca logo on the company's building in Shanghai, China. Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca. The Monday, May 26, 2014 announcement comes a week after AstraZeneca's board rejected a proposed $119 billion buyout offer from Pfizer, the world's second-biggest drugmaker by revenue. (AP Photo/Eugene Hoshiko, File)
0fe66e2392844714550f6a7067000c3c.jpg
In this May 4, 2014 photo, the Pfizer logo is displayed on the exterior of a former Pfizer factory in the Brooklyn borough of New York. Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca. The Monday, May 26, 2014 announcement comes a week after AstraZeneca's board rejected a proposed $119 billion buyout offer from Pfizer, the world's second-biggest drugmaker by revenue. (AP Photo/Mark Lennihan, File)
d89461629c904b11530f6a7067005865.jpg
The Pfizer logo is displayed on the exterior of a former Pfizer factory, Sunday, May 4, 2014, in the Brooklyn borough of New York. The pharmaceutical giant said, Monday, May 5, 2014, that their first-quarter profit dropped 15 percent due to cheaper generic competition continuing to reduce sales of multiple medicines and the end of some partnerships promoting other companies’ medicines. (AP Photo/Mark Lennihan)
